Antihypertensive Drugs Market : Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
Report Highlights
Antihypertensive Drugs Market – Scope of Report
TMR’s report on the global antihypertensive drugs market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global antihypertensive drugs market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global antihypertensive drugs market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the antihypertensive drugs market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global antihypertensive drugs market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global antihypertensive drugs market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global antihypertensive drugs market.
The report delves into the competitive landscape of the global antihypertensive drugs market. Key players operating in the global antihypertensive drugs market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global antihypertensive drugs market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market antihypertensive drugs.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
- Company websites, presentations, annual reports, white papers, technical paper, product brochure
- Internal and external proprietary databases and relevant patents
- National government documents, statistical databases, and market reports
- News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
- Industry Sources:
- WorldWideScience.org
- Elsevier, Inc.
- National Institutes of Health (NIH)
- PubMed
- NCBI
- Department of Health Care Service
- Trade Data Sources
- Trade Map
- UN Comtrade
- Trade Atlas
- Company Information
- OneSource Business Browser
- Hoover’s
- Factiva
- Bloomberg
- Mergers & Acquisitions
- Thomson Mergers & Acquisitions
- MergerStat
- Profound
Primary Research
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
- Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
- Helps in validating and strengthening secondary research findings
- Further develops the analysis team’s expertise and market understanding
- Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
- Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
- Purchasing/Sourcing managers, technical personnel, distributors
- Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
- Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
- Advanced Oncotherapy PLC
- Danfysik A/S
- Hitachi, Ltd.
- IBA Worldwide
- Mevion Medical Systems, Inc.
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
- Table 1 : Global Antihypertensive Drugs Market Size (US$ Bn) Forecast, by Therapy Type, 2017-2031
- Table 2 : Global Antihypertensive Drugs Market Size (US$ Bn) Forecast, by Diuretics, 2017-2031
- Table 3 : Global Antihypertensive Drugs Market Size (US$ Bn) Forecast, by Beta-blockers, 2017-2031
- Table 4 : Global Antihypertensive Drugs Market Size (US$ Bn) Forecast, by Type, 2017-2031
- Table 5 : Global Antihypertensive Drugs Market Size (US$ Bn) Forecast, by Medication Type, 2017-2031
- Table 6 : Global Antihypertensive Drugs Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031
- Table 7 : Global Antihypertensive Drugs Value (US$ Bn) Forecast, by Region, 2017-2031
- Table 8 : North America Antihypertensive Drugs Market Value (US$ Bn) Forecast, by Country, 2017-2031
- Table 9 : North America Antihypertensive Drugs Market Value (US$ Bn) Forecast, by Therapy Type, 2017-2031
- Table 10 : North America Antihypertensive Drugs Market Value (US$ Bn) Forecast, by Diuretics, 2017-2031
- Table 11 : North America Antihypertensive Drugs Market Size (US$ Bn) Forecast, by Beta-blockers, 2017-2031
- Table 12 : North America Antihypertensive Drugs Market Value (US$ Bn) Forecast, by Type, 2017-2031
- Table 13 : North America Antihypertensive Drugs Market Size (US$ Bn) Forecast, by Medication Type, 2017-2031
- Table 14 : North America Antihypertensive Drugs Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031
- Table 15 : Europe Antihypertensive Drugs Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
- Table 16 : Europe Antihypertensive Drugs Market Value (US$ Bn) Forecast, by Therapy Type, 2017-2031
- Table 17 : Europe Antihypertensive Drugs Market Value (US$ Bn) Forecast, by Diuretics, 2017-2031
- Table 18 : Europe Antihypertensive Drugs Market Value (US$ Bn) Forecast, by Beta-blockers, 2017-2031
- Table 19 : Europe Antihypertensive Drugs Market Value (US$ Bn) Forecast, by Type, 2017-2031
- Table 20 : Europe Antihypertensive Drugs Market Value (US$ Bn) Forecast, by Medication Type, 2017-2031
- Table 21 : Europe Antihypertensive Drugs Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031
- Table 22 : Asia Pacific Antihypertensive Drugs Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
- Table 23 : Asia Pacific Antihypertensive Drugs Market Value (US$ Bn) Forecast, by Therapy Type, 2017-2031
- Table 24 : Asia Pacific Antihypertensive Drugs Market Value (US$ Bn) Forecast, by Diuretics, 2017-2031
- Table 25 : Asia Pacific Antihypertensive Drugs Market Value (US$ Bn) Forecast, by Beta-blockers, 2017-2031
- Table 26 : Asia Pacific Antihypertensive Drugs Market Value (US$ Bn) Forecast, by Type, 2017-2031
- Table 27 : Asia Pacific Antihypertensive Drugs Market Value (US$ Bn) Forecast, by Medication Type, 2017-2031
- Table 28 : Asia Pacific Antihypertensive Drugs Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031
- Table 29 : Latin America Antihypertensive Drugs Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
- Table 30 : Latin America Antihypertensive Drugs Market Value (US$ Bn) Forecast, by Therapy Type, 2017-2031
- Table 31 : Latin America Antihypertensive Drugs Market Value (US$ Bn) Forecast, by Diuretics, 2017-2031
- Table 32 : Latin America Antihypertensive Drugs Market Value (US$ Bn) Forecast, by Beta-blockers, 2017-2031
- Table 33 : Latin America Antihypertensive Drugs Market Value (US$ Bn) Forecast, by Type, 2017-2031
- Table 34 : Latin America Antihypertensive Drugs Market Value (US$ Bn) Forecast, by Medication Type, 2017-2031
- Table 35 : Latin America Antihypertensive Drugs Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031
- Table 36 : Middle East & Africa Antihypertensive Drugs Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
- Table 37 : Middle East & Africa Antihypertensive Drugs Market Value (US$ Bn) Forecast, by Therapy Type, 2017-2031
- Table 38 : Middle East & Africa Antihypertensive Drugs Market Value (US$ Bn) Forecast, by Diuretics, 2017-2031
- Table 39 : Middle East & Africa Antihypertensive Drugs Market Value (US$ Bn) Forecast, by Beta-blockers, 2017-2031
- Table 40 : Middle East & Africa Antihypertensive Drugs Market Value (US$ Bn) Forecast, by Type, 2017-2031
- Table 41 : Middle East & Africa Antihypertensive Drugs Market Value (US$ Bn) Forecast, by Medication Type, 2017-2031
- Table 42 : Middle East & Africa Antihypertensive Drugs Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031
- Figure 1 : Global Antihypertensive Drugs Market Size Value (US$ Bn) Forecast, 2017-2031
- Figure 2 : Global Antihypertensive Drugs Market Value Share (%), by Therapy Type, 2017-2031
- Figure 3 : Global Antihypertensive Drugs Market Value Share (%), by Type, 2017-2031
- Figure 4 : Global Antihypertensive Drugs Market Value Share (%), by Distribution Channel, 2017-2031
- Figure 5 : Global Antihypertensive Drugs Market Value Share Analysis, by Therapy Type, 2017-2031
- Figure 6 : Global Antihypertensive Drugs Market Attractiveness Analysis, by Therapy Type, 2017-2031
- Figure 7 : Global Antihypertensive Drugs Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Diuretics, 2017-2031
- Figure 8 : Global Antihypertensive Drugs Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Angiotensin Converting Enzyme Inhibitors, 2017-2031
- Figure 9 : Global Antihypertensive Drugs Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Angiotensin Receptor Blockers, 2017-2031
- Figure 10 : Global Antihypertensive Drugs Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Beta-blockers, 2017-2031
- Figure 11 : Global Antihypertensive Drugs Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Vasodilators, 2017-2031
- Figure 12 : Global Antihypertensive Drugs Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Calcium Channel Blockers, 2017-2031
- Figure 13 : Global Antihypertensive Drugs Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Renin Inhibitors, 2017-2031
- Figure 14 : Global Antihypertensive Drugs Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Alpha-blockers, 2017-2031
- Figure 15 : Global Antihypertensive Drugs Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Others, 2017-2031
- Figure 16 : Global Antihypertensive Drugs Market Value Share Analysis, by Type, 2017-2031
- Figure 17 : Global Antihypertensive Drugs Market Attractiveness Analysis, by Type, 2017-2031
- Figure 18 : Global Antihypertensive Drugs Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Primary Hypertension, 2017-2031
- Figure 19 : Global Antihypertensive Drugs Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Secondary Hypertension, 2017-2031
- Figure 20 : Global Antihypertensive Drugs Market Value Share Analysis, by Medication Type, 2017-2031
- Figure 21 : Global Antihypertensive Drugs Market Attractiveness Analysis, by Medication Type, 2017-2031
- Figure 22 : Global Antihypertensive Drugs Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Monotherapy, 2017-2031
- Figure 23 : Global Antihypertensive Drugs Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Combination Therapy, 2017-2031
- Figure 24 : Global Antihypertensive Drugs Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Fixed Dose Combinations, 2017-2031
- Figure 25 : Global Antihypertensive Drugs Market Value Share Analysis, by Distribution Channel, 2017-2031
- Figure 26 : Global Antihypertensive Drugs Market Attractiveness Analysis, by Distribution Channel, 2017-2031
- Figure 27 : Global Antihypertensive Drugs Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Retail Pharmacies, 2017-2031
- Figure 28 : Global Antihypertensive Drugs Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2017-2031
- Figure 29 : Global Antihypertensive Drugs Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Online Pharmacies, 2017-2031
- Figure 30 : Global Antihypertensive Drugs Value Share, by Region, 2017-2031
- Figure 31 : Global Antihypertensive Drugs Attractiveness, by Region, 2017-2031
- Figure 32 : North America Antihypertensive Drugs Market Value (US$ Bn) and Y-o-Y Growth (%) Forecast, 2017-2031
- Figure 33 : North America Antihypertensive Drugs Market Value Share Analysis, by Country, 2017-2031
- Figure 34 : North America Antihypertensive Drugs Market Attractiveness Analysis, by Country, 2017-2031
- Figure 35 : North America Antihypertensive Drugs Market Value Share Analysis, by Therapy Type, 2017-2031
- Figure 36 : North America Antihypertensive Drugs Market Attractiveness Analysis, by Therapy Type, 2017-2031
- Figure 37 : North America Antihypertensive Drugs Market Value Share Analysis, by Type, 2017-2031
- Figure 38 : North America Antihypertensive Drugs Market Attractiveness Analysis, by Type, 2017-2031
- Figure 39 : North America Antihypertensive Drugs Market Value Share Analysis, by Medication Type, 2017-2031
- Figure 40 : North America Antihypertensive Drugs Market Attractiveness Analysis, by Medication Type, 2017-2031
- Figure 41 : North America Antihypertensive Drugs Market Value Share Analysis, by Distribution Channel, 2017-2031
- Figure 42 : North America Antihypertensive Drugs Market Attractiveness Analysis, by Distribution Channel, 2017-2031
- Figure 43 : Europe Antihypertensive Drugs Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
- Figure 44 : Europe Antihypertensive Drugs Market Value Share Analysis, by Country/Sub-region, 2017-2031
- Figure 45 : Europe Antihypertensive Drugs Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
- Figure 46 : Europe Antihypertensive Drugs Market Value Share Analysis, by Therapy Type, 2017-2031
- Figure 47 : Europe Antihypertensive Drugs Market Attractiveness Analysis, by Therapy Type, 2017-2031
- Figure 48 : Europe Antihypertensive Drugs Market Value Share Analysis, by Type, 2017-2031
- Figure 49 : Europe Antihypertensive Drugs Market Attractiveness Analysis, by Type, 2017-2031
- Figure 50 : Europe Antihypertensive Drugs Market Value Share Analysis, by Medication Type, 2017-2031
- Figure 51 : Europe Antihypertensive Drugs Market Attractiveness Analysis, by Medication Type, 2017-2031
- Figure 52 : Europe Antihypertensive Drugs Market Value Share Analysis, by Distribution Channel, 2017-2031
- Figure 53 : Europe Antihypertensive Drugs Market Attractiveness Analysis, by Distribution Channel, 2017-2031
- Figure 54 : Asia Pacific Antihypertensive Drugs Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
- Figure 55 : Asia Pacific Antihypertensive Drugs Market Value Share Analysis, by Country/Sub-region, 2017-2031
- Figure 56 : Asia Pacific Antihypertensive Drugs Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
- Figure 57 : Asia Pacific Antihypertensive Drugs Market Value Share Analysis, by Therapy Type, 2017-2031
- Figure 58 : Asia Pacific Antihypertensive Drugs Market Attractiveness Analysis, by Therapy Type, 2017-2031
- Figure 59 : Asia Pacific Antihypertensive Drugs Market Attractiveness Analysis, by Type, 2017-2031
- Figure 60 : Asia Pacific Antihypertensive Drugs Market Value Share Analysis, by Medication Type, 2017-2031
- Figure 61 : Asia Pacific Antihypertensive Drugs Market Attractiveness Analysis, by Medication Type, 2017-2031
- Figure 62 : Asia Pacific Antihypertensive Drugs Market Value Share Analysis, by Distribution Channel, 2017-2031
- Figure 63 : Asia Pacific Antihypertensive Drugs Market Attractiveness Analysis, by Distribution Channel, 2017-2031
- Figure 64 : Latin America Antihypertensive Drugs Market Value (US$ Bn) and Y-o-Y Growth (%) Forecast, 2017-2031
- Figure 65 : Latin America Antihypertensive Drugs Market Value Share Analysis, by Country/Sub-region, 2017-2031
- Figure 66 : Latin America Antihypertensive Drugs Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
- Figure 67 : Latin America Antihypertensive Drugs Market Value Share Analysis, by Therapy Type, 2017-2031
- Figure 68 : Latin America Antihypertensive Drugs Market Attractiveness Analysis, by Therapy Type, 2017-2031
- Figure 69 : Latin America Antihypertensive Drugs Market Value Share Analysis, by Type, 2017-2031
- Figure 70 : Latin America Antihypertensive Drugs Market Attractiveness Analysis, by Type, 2017-2031
- Figure 71 : Latin America Antihypertensive Drugs Market Value Share Analysis, by Medication Type, 2017-2031
- Figure 72 : Latin America Antihypertensive Drugs Market Attractiveness Analysis, by Medication Type, 2017-2031
- Figure 73 : Latin America Antihypertensive Drugs Market Value Share Analysis, by Distribution Channel, 2017-2031
- Figure 74 : Latin America Antihypertensive Drugs Market Attractiveness Analysis, by Distribution Channel, 2017-2031
- Figure 75 : Middle East & Africa Antihypertensive Drugs Market Value (US$ Bn) and Y-o-Y Growth (%) Forecast, 2017-2031
- Figure 76 : Middle East & Africa Antihypertensive Drugs Market Value Share Analysis, by Country/Sub-region, 2017-2031
- Figure 77 : Middle East & Africa Antihypertensive Drugs Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
- Figure 78 : Middle East & Africa Antihypertensive Drugs Market Value Share Analysis, by Therapy Type, 2017-2031
- Figure 79 : Middle East & Africa Antihypertensive Drugs Market Attractiveness Analysis, by Therapy Type, 2017-2031
- Figure 80 : Middle East & Africa Antihypertensive Drugs Market Value Share Analysis, by Type, 2017-2031
- Figure 81 : Middle East & Africa Antihypertensive Drugs Market Attractiveness Analysis, by Type, 2017-2031
- Figure 82 : Middle East & Africa Antihypertensive Drugs Market Value Share Analysis, by Medication Type, 2017-2031
- Figure 83 : Middle East & Africa Antihypertensive Drugs Market Attractiveness Analysis, by Medication Type, 2017-2031
- Figure 84 : Middle East & Africa Antihypertensive Drugs Market Value Share Analysis, by Distribution Channel, 2017-2031
- Figure 85 : Middle East & Africa Antihypertensive Drugs Market Attractiveness Analysis, by Distribution Channel, 2017-2031
Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.